01-03-2006 | Preclinical study
Nitric oxide attenuates resistance to doxorubicin in three-dimensional aggregates of human breast carcinoma cells
Published in: Breast Cancer Research and Treatment | Issue 2/2006
Login to get access01-03-2006 | Preclinical study
Published in: Breast Cancer Research and Treatment | Issue 2/2006
Login to get access